Anixa Biosciences, Inc. (ANIX)
3.48
-0.12
(-3.33%)
USD |
NASDAQ |
Aug 28, 16:00
3.59
+0.11
(+3.16%)
After-Hours: 20:00
Anixa Biosciences Stock Buybacks (Quarterly) : -1.249M for April 30, 2026
Stock Buybacks (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -1.249M |
| January 31, 2026 | -1.685M |
| October 31, 2025 | -0.35M |
| July 31, 2025 | -1.929M |
| April 30, 2025 | -0.018M |
| January 31, 2025 | 0.017M |
| October 31, 2024 | -0.106M |
| July 31, 2024 | -0.149M |
| April 30, 2024 | -0.897M |
| January 31, 2024 | -2.263M |
| October 31, 2023 | -0.279M |
| July 31, 2023 | -0.003M |
| April 30, 2023 | -0.081M |
| January 31, 2023 | -0.003M |
| October 31, 2022 | 0.384M |
| July 31, 2022 | -0.829M |
| April 30, 2022 | -0.007M |
| January 31, 2022 | 0.00 |
| October 31, 2021 | -0.1436M |
| July 31, 2021 | 0.00 |
| April 30, 2021 | -25.36M |
| January 31, 2021 | -6.061M |
| October 31, 2020 | -1.403M |
| July 31, 2020 | -4.851M |
| April 30, 2020 | -1.373M |
| Date | Value |
|---|---|
| January 31, 2020 | -1.780M |
| October 31, 2019 | -0.6678M |
| July 31, 2019 | -0.5646M |
| April 30, 2019 | -2.280M |
| January 31, 2019 | -2.176M |
| October 31, 2018 | -0.7423M |
| July 31, 2018 | -1.109M |
| April 30, 2018 | -0.6774M |
| January 31, 2018 | 0.00 |
| October 31, 2017 | -3.462M |
| July 31, 2017 | -3.212M |
| April 30, 2017 | -4.203M |
| January 31, 2017 | 0.4943M |
| October 31, 2016 | -0.0102M |
| July 31, 2016 | -0.0052M |
| April 30, 2016 | -0.0182M |
| January 31, 2016 | 0.00 |
| October 31, 2015 | -0.0103M |
| July 31, 2015 | 0.2109M |
| April 30, 2015 | 0.20M |
| January 31, 2015 | 0.00 |
| October 31, 2014 | -0.0246M |
| July 31, 2014 | -3.874M |
| April 30, 2014 | -0.1507M |
| January 31, 2014 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Stock Buybacks (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -29.86M |
| Oncolytics Biotech, Inc. | -6.704M |
| Sangamo Therapeutics, Inc. | -27.08M |
| Sarepta Therapeutics, Inc. | 0.00 |
| Vicapsys Life Sciences, Inc. | -0.135M |